Vicor director sells shares after option exercise
VICOR CORP director Andrew D'Amico reported an option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VICOR CORP director Andrew D'Amico reported an option exercise and share sale. He exercised options to acquire 754 shares of common stock at $53.07 per share and sold 754 shares at $330.00 per share in an open-market transaction.
Following these transactions, he reported no directly held common shares and 1,507 non-qualified stock options remaining, which are exercisable into common stock until June 23, 2033. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2024.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 754 | $0.00 | $0.00 |
| Exercise | Common Stock | 754 | $53.07 | $40K |
| Sale | Common Stock | 754 | $330.00 | $249K |
Footnotes (1)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Non Qualified Stock Option financial
derivative security financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did VICOR (VICR) director Andrew D'Amico report?
What options did Andrew D'Amico exercise in his VICOR (VICR) Form 4 filing?
Does Andrew D'Amico still hold VICOR (VICR) common stock after these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.